go back

Melanoma Versus Benign Mole Gene Test

Rhode Island rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $8,913 · 10th–90th $2,344$8,9130%50%10th$8,913Professionalmedian $1,380 · 10th–90th $1,175$1,4450%20%40%10th90th$1,380$1.0K$2.0K$5.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$5,623.41
Median
$8,912.51
Typical High
$8,912.51
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,380.38
Median
$1,380.38
Typical High
$1,445.44
BCBS
Setting
Facility
Modifier
Global
Typical Low
$2,344.23
Median
$2,344.23
Typical High
$2,344.23
United
Setting
Facility
Modifier
Global
Typical Low
$2,344.23
Median
$2,344.23
Typical High
$2,754.23
United
Setting
Professional
Modifier
Global
Typical Low
$812.83
Median
$1,174.90
Typical High
$2,818.38